Webin an effort to develop its specialty pharmacy business, cvs caremark (nyse:cvs) unveiled a $2. 1 billion deal on wednesday to acquire the specialty infusion.

Webdrugstore chain cvs caremark corp.

Completed its $2. 1 billion acquisition of the drug infusion business coram llc, and it expects the deal to start helping earnings.

Recommended for you
You may also like